Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    11 August 2022

    • curprev 23:1623:16, 11 August 2022‎ 187.21.138.9 talk‎ 557 bytes +557‎ Created page with "== Target Article == Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency; LG Gomes, G Madureira, BB Mendoncaae; 2013; doi_citing_unknown == Retraction == Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11ß-hydroxylase deficiency ; Firdevs Bas Nucin Saka Feyza Darendeliler Siki Tuzlah Ridvan Ilhan Ruveyde Bundak Hulya Gonuz; 06/01/2000 ; https://doi.or..."
Retrieved from "https://wikicitingretracted.org/index.php?title=Mineralocorticoid_replacement_during_infancy_for_salt_wasting_congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency"